Rhinitis/rhinorrhea (Intranasal Products)

Odactra Available for House Dust Mite-Induced Allergic Rhinitis

By January 10, 2018

Odactra is an allergen extract indicated as immunotherapy for house dust mite (HDM)-induced allergic rhinitis.

New Treatment Option for Recurrent Nasal Polyps Gets FDA Approval

By December 11, 2017

The Sinuva Sinus Implant is a corticosteroid-eluting (mometasone furoate) implant indicated for the treatment of nasal polyps.

FlutiCare Nasal Spray Now Available OTC to Relieve Allergy Symptoms

By November 14, 2017

FlutiCare will be available OTC with the same prescription strength and same delivery method as Flonase and ClariSpray.

Seasonal Allergic Rhinitis Treatment Guidelines Updated

By November 07, 2017

The guidelines focus on three key clinical statements.

HydraSense Nasal Care Line Available for Infants and Children

By November 01, 2017

hydraSense hydrates and soothes dry and uncomfortable nasal passages.

Xhance Nasal Spray Approved to Treat Nasal Polyps

By September 20, 2017

Xhance was evaluated in five trials enrolling >1,500 adults.

Obstructive Sleep Apnea and Elevated Blood Coagulability: Is There a Link?

August 18, 2017

Significant differences were identified in PT seconds for the control group versus the moderate and severe OSA groups (mean, 11.26 versus 10.74 and 10.67, respectively).

Capsaicin Nasal Spray Evaluated in Patients with Mixed Rhinitis

July 20, 2017

"In conclusion, the capsaicin nasal spray is effective in a broader group of IR than the purely selected ones described before," the authors wrote.

New Supplement Available for Relief of Allergy Symptoms

By May 24, 2017

In aclinical trial, AllerVarx decreased total symptom scores by ~70% and decreased the use of anti-allergic meds by ~73%.

Sinuva Implant for Chronic Sinusitis to Be FDA Reviewed

By May 23, 2017

The Sinuva implant releases mometasone furoate to the ethmoid sinus lining and is intended to treat chronic sinusitis patients who have recurrent sinus obstruction.

EAACI: Position Paper on Non-Allergic Rhinitis Management

May 11, 2017

The authors note that diagnosis of NAR is based on a detailed medical history and exclusion of clinically relevant sensitization to airborne allergens, and exclusion of clinical signs of rhinosinusitis.

Uncontrolled Allergic Rhinitis Impacts Work Productivity

April 14, 2017

Symptoms of allergic rhinitis controlled in about 60 percent of days according to mobile phone app

Serum Periostin Investigated as Rhinosinusitis Identifier

March 21, 2017

Receiver operating curve analyses showed moderate and high diagnostic accuracy for detecting chronic rhinosinusitis and chronic rhinosinusitis with nasal polyps, respectively.

Odactra Approved for House Dust Mite Allergies

By March 02, 2017

Odactra provides patients an alternative treatment to allergy shots.

Steroid-Releasing Implant Improves Surgical Outcomes in Chronic Sinusitis

By February 24, 2017

Propel Contour features an hourglass design and is specifically designed to conform to the sinus ostia.

Flonase Sensimist Available OTC for Allergy Relief

By February 08, 2017

GSK Consumer Healthcare announced the availability of Flonase Sensimist Allergy Relief (fluticasone furoate), an over-the-counter (OTC) treatment for symptoms associated with seasonal and perennial allergies for patients aged ≥12 years.

Cell Expression May ID Severity of Chronic Rhinosinusitis

February 02, 2017

Programmed cell death 1 (PD-1) expression is associated with chronic rhinosinusitis with nasal polyps (CRSwNP) disease severity, according to a study published online in Allergy.

Verapamil May Be Effective in Severe Chronic Rhinosinusitis

By January 23, 2017

Verapamil, a calcium channel blocker, has shown significant efficacy in alleviating symptoms of patients with chronic rhinosinusitis (CRS) with nasal polyps.

Treatments for Pollen-Related Allergic Rhinoconjunctivitis Compared

October 11, 2016

Findings based on number of symptom-free days for daily versus as-needed treatment

Intranasal Therapies Evaluated for Reducing HHT-Related Epistaxis

September 07, 2016

Saline as good as medications for hereditary hemorrhagic telangiectasia, researchers find

Beneficial Therapy Underutilized in Chronic Rhinosinusitis

August 29, 2016

Rate of intranasal steroid spray utilization 20.1 per 100 patients; geographic variation in rate

FDA Approves New Rx-to-OTC Switch for Allergy Nasal Spray

By August 03, 2016

The OTC treatment is for symptoms associated with seasonal and perennial allergies in patients aged ≥2 years.

Nasal Irrigation, Steam Inhalation Evaluated in Chronic Sinusitis

July 19, 2016

Steam inhalation may ease headaches, but no significant improvement in RSDI scores

Rhinase Gel and Mist Launched for Nasal Dryness

By July 19, 2016

Profounda announced the launch of Rhinase Soothing Nasal Gel and Rhinase Lubricating Nasal Mist for use in patients with nasal dryness associated with allergies, low humidity, stuffy nose, and nosebleeds.

Are OTC Nasal Dilators Effective?

By June 30, 2016

A recent review in JAMA Facial Plastic Surgery examines the effectiveness of over-the-counter (OTC) mechanical nasal dilators in improving airflow through the internal nasal valve.

Review Compares Intranasal Steroid Preparations for Chronic Rhinosinusitis

By April 28, 2016

For patients with chronic rhinosinusitis, study authors found insufficient data to suggest that one type of intranasal steroid was more effective than another.

Xylitol-Based Nasal Care Products Available OTC

By April 20, 2016

Xlear have announced that their line of xylitol-based products for adults with upper respiratory problems will be available at 1,300 Target stores nationwide.

9/11 Firefighters Twice as Likely to Need Surgery for Chronic Rhinosinusitis

April 11, 2016

Sinus surgery is more common among firefighters who responded during the first 2 days of the World Trade Center disaster than those who had less intense or shorter exposures.

What Effect Does Allergen Immunotherapy Have on Allergic Rhinitis?

March 29, 2016

Dermatophagoides pteronyssinus (DP) subcutaneous allergen immunotherapy (AIT) seems safe and effective for local allergic rhinitis (LAR), according to a study published online in Allergy.

Apotex Launches Generic Nasonex

By March 22, 2016

Apotex announced the launch of Mometasone Furoate Monohydrate Nasal Spray, the generic version of Merck's Nasonex.